bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2009. Net sales amounted to €1,223 million in 2009, an increase of 7.7% from the €1,111 million reported in 2008, at constant exchange rates and scope of consolidation (like-for-like). For the fourth quarter alone, net sales amounted to €328 million, compared to €311 million for the prior-year period, up 7.5% like-for-like.